Zen Graphene Solutions logo imageZEN Graphene Solutions, formerly called Zenyatta Ventures, is a mineral exploration and development company based in Ontario, Canada. Zen is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.

The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zen has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.

According to the Zen, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.

Company Address: 
1224 Amber Drive
Thunder Bay, ON P7B 6M5
Canada

The latest ZEN Graphene news:

Companies respond to graphene masks "health hazard" scare

Following recent concerns surrounding the use of graphene in face masks and Health Canada's warnings of "a potential that wearers could inhale graphene particles from some masks, which may pose health risks", several companies involved in the production of such masks released their comments on the matter.



Zen Graphene Solutions, which developed a graphene-based virucidal ink and reported that it has a 99% effectiveness against COVID-19, released a statement saying that it is aware of the recent claims, and "is aligned and supportive of the steps taken to regulate the use of graphene and remove products that are unsafe for the public". It went on to state that its own products have been found safe in various "comprehensive testing". Later on, Zen also submitted various data requested by Health Canada - including final results received from Nucro-Technics on skin irritation and sensitivity that confirmed ZENGuard™ did not lead to any irritation or sensitivity.

ZEN Graphene Solutions doubles size of private placement

Zen Graphene Solutions logo imageZEN Graphene Solutions recently announced a non-brokered private placement, for gross proceeds of up to CAD$2,000,000 (around USD$1.59 million). Now, Zen has updated that due to "strong demand", it has increased the size of the Offering.

The gross proceeds will now be up to CDN$4,000,000 (over USD$3.16 million) - doubling the initial planned total.

<--break->The proceeds of this offering will be used for capital expenditures in the scale up of the production of ZEN's biocidal coating material, operating expenses at both Guelph locations, capital expenditures at the York Rd, Guelph manufacturing facility, graphene research and for general working capital.

Zen Graphene Solutions announces non-brokered private placement

Zen Graphene Solutions logo imageZEN Graphene Solutions has announced a non-brokered private placement, for gross proceeds of up to CAD$2,000,000 (around USD$1.59 million).

The proceeds of this offering will be used for capital expenditures in the scale up of the production of ZEN's biocidal coating material, operating expenses at both Guelph locations, capital expenditures at the York Rd, Guelph manufacturing facility, graphene research and for general working capital.

Zen Graphene Solutions and TreborRx announce nitrile glove agreement

Zen Graphene Solutions has announced an agreement reached on January 16th with TreborRx (Trebor) for application of its graphene-based coating on nitrile gloves sourced or produced by Trebor.

ZEN will provide Trebor with a distribution agreement for Canada, the USA and Mexico. Trebor agrees to use the coating on all gloves sold and will pay ZEN a royalty per glove coated, with a minimum first year guarantee of 100 million gloves.

Zen Graphene Solutions develops graphene-based potential treatment for bacterial and viral Infections

Zen Graphene Solutions logo imageZEN Graphene Solutions has announced that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound.

Recent testing results from the University Health Network/Mount Sinai Hospital Department of Microbiology in Toronto are said to indicate that this patent pending formulation could be a medical breakthrough in the treatment of numerous human-contracted pathogens including upper and lower respiratory tract infections - where COVID-19 is a major contributor - as well as drug resistant organisms.

Tags: